NLRP1 and peripheral arterial disease: Despite the encouraging evidence on the role and potential therapeutic implications of NLRP1 inflammasome, especially in peripheral arterial disease, studies of direct or indirect inhibitors are largely lacking, constituting an important knowledge gap.